Biotricity Operating Cash Flow Growth & History (BTCY)

Biotricity's operating cash flow was −$718,955 for fiscal 2026.

View full Biotricity company overview

Biotricity annual operating cash flow history

Biotricity annual operating cash flow

Fiscal yearPeriod endedOperating cash flowChangeGrowth
20262026-03-31−$718,955$1.7M
20252025-03-31−$2.4M$4.3M
20242024-03-31−$6.7M$6.9M
20232023-03-31−$13.5M$1.6M
20222022-03-31−$15.2M−$4.1M
20212021-03-31−$11.1M−$3.2M
20202020-03-31−$7.9M−$2.6M
20192019-03-31−$5.2M−$346,312
20182018-03-31−$4.9M−$1.1M
20172017-03-31−$3.7M−$1.9M
2016 · Dec 312016-12-31−$2.4M−$419,664
2016 · Mar 312016-03-31−$1.8M
2015 · Dec 312015-12-31−$2.0M
2015 · Aug 312015-08-31−$26,951−$18,729
20142014-08-31−$8,222

Biotricity operating cash flow trends

Over the last five fiscal years, Biotricity's operating cash flow increased from −$11.1M to −$718,955, a change of $10.4M. The latest reported quarter, Q1 2027, shows $507,227.

About the metric

What operating cash flow means

Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.

Calculation and source

SEC-reported operating cash flow

TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Biotricity source filings ↗

Community posts

It’s quiet here.

No posts about BTCY yet. Start the conversation.

Write the first post